Federal court backs FDA approval of Jazz sleep drug competitor

The US District Court for Washington, DC, on Wednesday ruled against Jazz Pharmaceuticals' attempt to undo the FDA's approval of a competing sleep drug from Avadel Pharmaceuticals that uses the same active ingredient but can ...